Novelrad
Minimally-invasive Suturing for Vascular and Heart Defect Closure
Startup Pre-Funding Health Tech & Life Sciences Est. 2019
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
1 rounds
Team
2
1-10 employees
Confidence
90/100
News
1
articles
About
Novelrad has developed a micro sewing machine that can deploy a range of continuous suture patterns, percutaneously, with a simple click of a button. The versatile suturing platform mimics the surgical ‘gold standard’ and can address multiple indications in the cardiovascular system and beyond. The device deploys a multipoint purse string suture at the beginning of the procedure, thereby, enabling safe dilation and reliable closure at the end of the procedure. The Novelrad VCD features an unprecedented range of bore sizes using a single device.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
medical-devicessurgeonsvascularsurgery-tools
Funding & Events
Feb 2024
Non-equity Undisclosed
EIC Accelerator
News (1)
Feb 29, 2024 · rasph.com
growth-positive
Unveiling the Latest EIC Accelerator Results: A Comprehensive Analysis (November 8th 2023 Cut-Off, February 2024 Release) - Rasph - EIC Accelerator Consulting
Investment
Details
Product Stage
Released
Employees
1-10
Exact Count
10
Founded
2019
Registrar
515962033
Locations
Metzer, Israel
Links
Website
LinkedIn
Admin
Last Update
Mar 13, 2025
Verified by
Yanina Wainscheinker
Missing
funding rounds, markets, not claimed
Team (2)
Netanel Sharabani
Co-founder & CEO
Founder
Ori Goldor
Co-founder & R&D Manager
Founder
Internal
Created by
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)
Created
2023-05-19T00:00:00.000Z
Last editor
Matan Eblagon (matane@sncentral.org)